Efficacy and Safety Study of Peginterferon Alfacon-2 to Treat Chronic Hepatitis B Virus Infection

NCT06544551 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

336

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis B Virus Infection

Interventions

DRUG: Peginterferon Alfacon-2
DRUG: Peginterferon Alfacon-2 placebo

Sponsor

Beijing Kawin Technology Share-Holding Co., Ltd.